Aurobindo Pharma
Aurobindo Pharma CMP 616
The stock is likely to have made a double bottom.
Target 656
The stock is likely to have made a double bottom.
Target 656
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.